View annual counts of Accidental or Undetermined overdose deaths for 2012 forward, including provisional estimates of annual counts of overdose deaths for recent years, as noted with an asterisk and the month the data was pulled.
NOTE: Finalized death records for overdose deaths are often delayed by 3-6 months. Counties labeled “no value” have data suppressed because the counts are between 1 and 9.
Dataset includes overdose deaths where the Manner of Death is Accidental or Undetermined.
County complement counts file located here - https://data.pa.gov/Opioid-Related/Estimated-Accidental-and-Undetermined-Drug-Overdos/azzc-q64m

Overdose Deaths are classified using the International Classification of Diseases, Tenth Revision (ICD–10). Accidental and Undetermined drug overdose deaths are identified using underlying cause-of-death codes X40–X44, and Y10–Y14, and include
- R99 when the Injury Description indicates an overdose death.
- X49 when literal COD is Mixed or Combined or Multiple Substance Toxicity, as these are likely drug overdoses
- X47 when substance indicated is difluoroethane, alone or in combination with other drugs
Source Pennsylvania Prescription Drug Monitoring Program *
* These data were supplied by the Bureau of Health Statistics and Registries, Harrisburg, Pennsylvania. The Bureau of Health Statistics and Registries specifically disclaims responsibility for any analyses, interpretations or conclusions.
- Estimates are broken down by type of drugs involved in the overdose
- Any Drug Overdose Death - all drug overdose deaths, regardless of type of drug involved, excluding alcohol only deaths
- Opioid Overdose Death - any overdose death involving opioids, prescription or illegal

This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

This dataset contains aggregate data by ethnicity for individuals that received a COVID vaccination. Data includes counts of individuals who received a vaccine dose that provides partial coverage against the disease and counts of individuals that received a vaccine dose that provides full coverage against the disease. Suppression applies for quantities less than 5.

Data only includes information reported to PA-SIIS, the Pennsylvania Statewide Immunization Information System.

Fully Vaccinated means that the person has received the necessary number of COVID-19 vaccines at the recommended time intervals.

First Booster Doses (Administered Since August 13, 2021)

First Booster doses administered since August 13, 2021 includes vaccinations beyond the primary series administered to the suggested groups at the recommended intervals on or after 08-13-2021 following CDC guidelines. Such vaccinations are commonly called booster doses. This category also includes additional does of COVID vaccine administered on or after 08-13-2021 to immunocompromised individual at the CDC recommended interval.

Second Booster Doses (Administered Since March 29, 2022)

Second booster doses administered since March 29, 2022 includes mRNA vaccinations beyond the primary series and one additional COVIDS vaccine as a second booster dose administered on or after 03-29-2022 to individuals ages 50+ at the recommended intervals per CDC guidelines. This category also includes additional doses of mRNA COVID vaccines administered on or after 03-29-2022 to immunocompromised individual at the CDC recommended internal.

This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

This dataset contains aggregate data by gender for individuals that received a COVID vaccination. Data includes counts of individuals who received a vaccine dose that provides partial coverage against the disease and counts of individuals that received a vaccine dose that provides full coverage against the disease. Suppression applies for quantities less than 5.

Data only includes information reported to PA-SIIS, the Pennsylvania Statewide Immunization Information System.

Fully Vaccinated means that the person has received the necessary number of COVID-19 vaccines at the recommended time intervals.

First Booster Doses (Administered Since August 13, 2021)

First Booster doses administered since August 13, 2021 includes vaccinations beyond the primary series administered to the suggested groups at the recommended intervals on or after 08-13-2021 following CDC guidelines. Such vaccinations are commonly called booster doses. This category also includes additional does of COVID vaccine administered on or after 08-13-2021 to immunocompromised individual at the CDC recommended interval.

Second Booster Doses (Administered Since March 29, 2022)

Second booster doses administered since March 29, 2022 includes mRNA vaccinations beyond the primary series and one additional COVIDS vaccine as a second booster dose administered on or after 03-29-2022 to individuals ages 50+ at the recommended intervals per CDC guidelines. This category also includes additional doses of mRNA COVID vaccines administered on or after 03-29-2022 to immunocompromised individual at the CDC recommended internal.

This data set includes the estimated number of individuals in Pennsylvania with Drug Use Disorder, which is an approximation for Opioid Use Disorder prevalence. The estimates are developed by applying mortality weights derived from the CDC’s National Center for Health Statistics to statewide illicit drug use estimates from the National Survey on Drug Use and Health (NSDUH, sponsored by the Substance Abuse and Mental Health Services Administration).

This dataset contains aggregate data by clinic for COVID-19 doses that are reported to the Pennsylvania Statewide Immunization System (PA-SIIS) as waste or spoilage.

Data includes the name, address and county of the clinics and the quantities of doses reported based on CDC’s standard waste reason codes or spoilage.

Spoilage is defined as nonviable, unopened vials of vaccine. This typically includes vaccine that has expired and vaccine that was not kept stored at the correct temperature (due to conditions such as equipment failure).

Wastage is defined as nonviable doses from opened vials. Standard CDC reasons are as follows:



• Broken Vial or Syringe

• Vaccine drawn (into syringe) but not administered

• Lost or unaccounted for vaccine

• Open vial but not administered

• Other



Data only includes information reported to PA-SIIS, the Pennsylvania Statewide Immunization Information System. Providers participating in the COVID-19 Program that are located in Philadelphia County or who are receiving vaccine inventory directly from CDC are not included in this dataset since they do not report inventory information to PA-SIIS.

EDDIE is an interactive health statistics dissemination web tool where you can create customized data tables for various health related data.

The EDDIE system was developed to empower public health professionals by enhancing and expanding upon their ability to use data and statistics to drive public health policy and program decisions. Users of the EDDIE system must agree to make no attempt to identify an individual, and must agree to notify the Pennsylvania Department of Health, Division of Health Informatics immediately if an individual is inadvertently identified along with an explanation on how this occurred.

The following datasets are available:
•Air Quality
•Behavioral Risk Factor Surveillance System (BRFSS)
•Birth Defects
•Births
•Cancer Incidence
•Carbon Monoxide Poisoning Mortality
•Childhood Cancer Incidence
•Childhood Lead Poisoning
•Children Less Than Age 5 Living in Poverty
•Communicable Diseases (other than STDs)
•Deaths
•Drinking Water Quality
•Hospitalizations
•Housing by Year Built
•Infant Deaths
•Population
•Reported Pregnancies
•Reproductive Health Outcomes
•Sexually Transmitted Diseases (STDs)

EDDIE is the Pennsylvania Department of Health's primary tool for data dissemination. This is also the replacement for our legacy EpiQMS system, which has been disabled. We are working to add additional functionality to the EDDIE system in the future, including charts, county assessments, and additional maps. We are also planning to add new datasets in the coming years.

​DISCLAIMER: If you use any of the data provided, please include the following statement in any publication or release:
These data were provided by the Division of Health Informatics, Pennsylvania Department of Health. The Department specifically disclaims responsibility for any analyses, interpretations, or conclusions. Users of this data agree to make no attempt to identify an individual, and agree to notify the Division of Health Informatics, Pennsylvania Department of Health immediately if an individual is inadvertently identified along with an explanation of how this occurred.

View quarterly trends in Risky Prescribing Measures, including:
o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence.
o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence.
o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence.
o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence.
Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

Based on Emergency Department (ED) Visits view quarterly trends in overdose rates for Any Drug Overdoses, Any Opioid Overdoses and Heroin Overdoses at the state and county level. Please see Overdose Data Technical Notes for additional details: http://www.health.pa.gov/Your-Department-of-Health/Offices%20and%20Bureaus/PaPrescriptionDrugMonitoringProgram/Documents/OverdoseDataTechnicalNotes.pdf
Syndromic surveillance is the analysis of medical data to detect or anticipate disease outbreaks. According to a CDC definition, "the term 'syndromic surveillance' applies to surveillance using health-related data that precede diagnosis and signal a sufficient probability of a case or an outbreak to warrant further public health response.